bs-0051R-Cy7 [Conjugated Primary Antibody]
MLANA/MART1 Polyclonal Antibody, Cy7 Conjugated
www.biossusa.com
[email protected]
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Host: Rabbit

Target Protein: MLANA/MART1

Immunogen Range: 51-118/118


Clonality: Polyclonal

Isotype: IgG

Entrez Gene: 2315

Swiss Prot: Q16655

Source: KLH conjugated synthetic peptide derived from human MLANA/MART1

Purification: Purified by Protein A.

Storage Buffer: Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Storage: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Background:

Involved in melanosome biogenesis by ensuring the stability of GPR143. Plays a vital role in the expression, stability, trafficking, and processing of melanocyte protein PMEL, which is critical to the formation of stage II melanosomes.

Conjugation: Cy7

Excitation/ Emission: 743nm/767nm

Size: 100ul

Concentration: 1ug/ul

Applications: IF(IHC-P)(1:50-200)
IF(IHC-F)(1:50-200)
IF(ICC)(1:50-200)

Predicted Molecular Weight: 13


Cross Reactive Species: Human

For research use only. Not intended for diagnostic or therapeutic use.

PRODUCT SPECIFIC PUBLICATIONS
  • Liu Chang. et al. Development and Validation of an Autophagy-Related Signature for Head and Neck Squamous Cell Carcinoma. Biomed Res Int. 2021;2021:1028158Read more>>
  • Zhang Yushan. et al. Establishment and validation of evaluation models for post-inflammatory pigmentation abnormalities. FRONT IMMUNOL. 2022 Oct;0:6492Read more>>